Procter & Gamble Health Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2024 | Jun 2024 | Mar 2024 |
|---|---|---|---|
| Revenue | 316.69 | 286.01 | 254.75 |
| Operating Expense | 199.37 | 255.82 | 185.04 |
| Net Profit | 82.33 | 16.78 | 46.56 |
| Net Profit Margin | 26.00 | 5.87 | 18.28 |
| Earning Per Share | 49.60 | 9.50 | 28 |
| EBIDTA | 116.20 | 36.93 | 69.85 |
| Effective Tax Rate | 23.82 | 42.37 | 23.38 |
| Particulars | Sep 2024 |
|---|---|
| Revenue | 316.69 |
| Operating Expense | 199.37 |
| Net Profit | 82.33 |
| Net Profit Margin | 26.00 |
| Earning Per Share | 49.60 |
| EBIDTA | 116.20 |
| Effective Tax Rate | 23.82 |
Invest in Procter & Gamble Health Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|
| Total Revenue Annual | 1,151.26 | 1,229.62 | 1,114.41 |
| Operating Expenses Annual | 845.26 | 904.94 | 846.73 |
| Operating Profit Annual | 301.44 | 343.07 | 280.87 |
| Interest Annual | 0.72 | 0.77 | 0.42 |
| Depreciation | 27.40 | 28.10 | 27.08 |
| Net Profit Annual | 200.98 | 229.47 | 192.52 |
| Tax Annual | 72.34 | 84.73 | 60.85 |
| Particulars | Jun 2024 |
|---|---|
| Total Revenue Annual | 1,151.26 |
| Operating Expenses Annual | 845.26 |
| Operating Profit Annual | 301.44 |
| Interest Annual | 0.72 |
| Depreciation | 27.40 |
| Net Profit Annual | 200.98 |
| Tax Annual | 72.34 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|
| Cash Flow at the Beginning | 435.42 | 319.40 | 464.05 |
| Cash Flow from Operations | 228.28 | 236.01 | 169.52 |
| Cash Flow from Investing | -6.87 | -21.50 | -25.54 |
| Cash Flow from Financing | -418.10 | -98.49 | -288.63 |
| Cash Flow at the End | 238.73 | 435.42 | 319.40 |
| Particulars | Jun 2024 |
|---|---|
| Cash Flow at the Beginning | 435.42 |
| Cash Flow from Operations | 228.28 |
| Cash Flow from Investing | -6.87 |
| Cash Flow from Financing | -418.10 |
| Cash Flow at the End | 238.73 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|
| PBDIT Margin (%) | 26.18 | 27.90 | 25.20 |
| PBIT Margin (%) | 23.80 | 25.62 | 22.77 |
| PBT Margin (%) | -9.26 | -7.65 | -31.45 |
| Net PROFIT Margin (%) | 17.46 | 18.66 | 17.28 |
| Return On Networth / Equity (%) | 31.18 | 33.56 | 29.17 |
| Return On Networth /Employed (%) | 39.76 | 43.16 | 35.97 |
| Return On Assets (%) | 29.15 | 31.54 | 27.30 |
| Total Debt / Equity (X) | 0.02 | 0.01 | 0.01 |
| Asset Turnover Ratio (%) | 1.67 | 1.69 | 1.58 |
| Particulars | Jun 2024 |
|---|---|
| PBDIT Margin (%) | 26.18 |
| PBIT Margin (%) | 23.80 |
| PBT Margin (%) | -9.26 |
| Net PROFIT Margin (%) | 17.46 |
| Return On Networth / Equity (%) | 31.18 |
| Return On Networth /Employed (%) | 39.76 |
| Return On Assets (%) | 29.15 |
| Total Debt / Equity (X) | 0.02 |
| Asset Turnover Ratio (%) | 1.67 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Jun 2024 | Jun 2023 | Jun 2022 |
|---|---|---|---|
| Fixed Assets Annual | TBA | TBA | 109.06 |
| Total Current Assets Annual | TBA | TBA | 608.04 |
| Non Current Assets Annual | TBA | TBA | 280.08 |
| Total Shareholders Funds Annual | TBA | TBA | 616.49 |
| Total Assets Annual | TBA | TBA | 888.12 |
| Particulars | Jun 2024 |
|---|---|
| Fixed Assets Annual | TBA |
| Total Current Assets Annual | TBA |
| Non Current Assets Annual | TBA |
| Total Shareholders Funds Annual | TBA |
| Total Assets Annual | TBA |
No Data Availabe
